Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint®

IRVINE, CALIF., U.S., AND AMSTERDAM, NETHERLANDS - May 29, 2020 - Agendia, Inc., a world leader in precision oncology for breast cancer, today announced new data from MINDACT, the prospective randomized trial designed to further demonstrate the clinical utility of MammaPrint® risk scoring when determining a breast cancer patient’s need for chemotherapy

Shivom Launches FREE Informatics – Secure Health Data Sharing Solutions to Organisations Studying COVID-19.

LONDON, UNITED KINGDOM - May 29, 2020 -  Shivom Ventures Limited “Shivom” today announced the startup will be playing its part in combating the deadly coronavirus disease by offering researchers and pharmaceutical companies a 1-year free subscription to interrogate both viral and human genomes separately from RAW sequencing data

BOC Sciences Adds Featured SARS-CoV-2 Inhibitors for Drug Discovery

SHIRLEY, NY, UNITED STATES - May 29, 2020 - In recent days, BOC Sciences, one of the world’s leading chemical and pharmaceutical provider, announced to add more than 100 inhibitors of SARS-CoV-2 to its present inhibitor base to help the drug discovery of scientific research institutions during the COVID-19 pandemic

Elucid Digital Health reduces smart Pill Connect bottle to a smart cap dispenser which can fit on any medicine bottle

MANCHESTER, UNITED KINGDOM - May 28, 2020 -  

• The Elucid Digital Health screw on dispenser cap + app prompts compliance, messages patients, records temperature and humidity and provides real time reports for doctors or monitors

• Compliance in clinical trials is a serious problem with patients failing to comply - deteriorating as the trial progresses

• Non-compliance is estimated by the OECD to cause 200,000 premature deaths in Europe and estimated to cost E 125 billion in EU $105 billion in the US annually in avoidable hospitalisations, emergency care, and outpatient visitsx

CD Genomics Launches NGS Panels for SARS-CoV-2 Detection and Research

SHIRLEY, NY, UNITED STATES - May 20, 2020 - CD Genomics has developed a very comprehensive NGS panels for sequencing, coronaviruses detection, phylogenetic analysis and molecular characterization of the 2019 novel coronavirus (namely SARS-CoV-2, and the virus is responsible for COVID-19)

ERT helps medical researchers accelerate clinical trials with AI-assistance from Dynatrace

WALTHAM, MA, UNITED STATES - May 28, 2020 - Software intelligence company Dynatrace (NYSE: DT), today announced that ERT – a developer of software and devices used by medical researchers in 75% of FDA approved clinical trials in 2019 – is using Dynatrace® to automate DevOps processes, and speed up delivery of new applications, from an average of six weeks to as little as two weeks

Alfa Chemistry Testing Lab Releases Nano-products Safety Evaluation Services

NEW YORK, NY, UNITED STATES - May 28, 2020 - Earlier this month in May, 2020, Alfa Chemistry Testing Lab, a professional testing and analysis organization, announced to have released nano-products safety evaluation services for companies and agencies that are engaged with the development and application of nano-products

Research at MDI Biological Laboratory Explores Novel Pathways of Regeneration and Tumorigenesis

BAR HARBOR, ME, UNITED STATES - May 27, 2020 - Research by scientists at the MDI Biological Laboratory in Bar Harbor, Maine, is opening up new approaches to promoting tissue regeneration in organs damaged by disease or injury

Biodesy Announces Corporate Name Change to BlueLight Therapeutics

SOUTH SAN FRANCISCO, CA, UNITED STATES - May 27, 2020 - Biodesy Inc. today announced that it has changed its corporate name to BlueLight Therapeutics Inc., effective May 20, 2020, and appointed drug discovery expert Mark Gallop, PhD, as Chief Scientific Officer

AI & Medicine — An Expert in AI-aided Drug Discovery and Medical Applications

NEW YORK, NY, UNITED STATES - May 27, 2020 - Recently founded, the New York-based company AI & Medicine is an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applications

Alfa Chemistry Offers PEG linkers for the Science Community in Bioconjugation and Pegylation

NEW YORK, NY, UNITED STATES - May 27, 2020 - Earlier this month in May, 2020, the world's leading chemical supplier Alfa Chemistry announced that a total of close to 800 PEG linker products are now available for its customers worldwide, including acid PEG linkers, alkyl PEG linkers, amino PEG linkers, azido PEG linkers, benzyl PEG linkers, biotin PEG linkers, fmoc PEG linkers, NHBoc PEG linkers, NHS ester PEG linkers, t-butyl ester PEG linkers, THP PEG linkers, and other PEG Linkers

2bPrecise Solution Wins 2020 MedTech Breakthrough Award

PITTSBURGH, PA, UNITED STATES - May 26, 2020 - 2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, has been recognized as the “Best Overall Genomics Solution” in the fourth annual MedTech Breakthrough Awards program

ALBUMEDIX ANNOUNCE JONAS SKJØDT MØLLER AS NEW CHIEF EXECUTIVE OFFICER

NOTTINGHAM, ENGLAND - May 26, 2020 - Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the company’s leadership

Successful partnership between MolPort and BioAscent reaches 100-project milestone

BEACON, NY - May 26, 2020 - Successful partnership between MolPort and BioAscent reaches 100-project milestonePartnership enhances customer service and simplifies logistics of compound sourcing for scientists MolPort Inc

EchelonDx Launches Mobile COVID-19 Testing and Vaccination Verification Application to Help Reopen Local Businesses, Restore Employment and Revive Economic Growth

RENO, NV, UNITED STATES - May 26, 2020 - Echelon Diagnostics, Inc., a leading provider of genomic healthcare AI imaging and big data solutions, today announced the commercial launch of the SafeKey™ Health Passport (Patent Pending)

Rho to Coordinate Study Sponsored by National Institute of Allergy and Infectious Diseases to Determine Rate of COVID-19 Infection in US Children

DURHAM, NC, US - May 21, 2020 - For Immediate Release Rho to Coordinate Study Sponsored by National Institute of Allergy and Infectious Diseases to Determine Rate of COVID-19 Infection in US ChildrenNIH-funded study also aims to identify percentage of children infected with the new coronavirus that develop symptoms of the disease Research Triangle Park, NC - May 21, 2020 - Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced it is coordinating a new study, called Human Epidemiology and Response to SARS-CoV-2 (HEROS), to help determine the rate of the new coronavirus infection in children and their family members in the U

Microway Supports AI Leaders, Delivers First NVIDIA DGX A100 to a US Educational Institution

PLYMOUTH, MA, UNITED STATES - May 20, 2020 - Microway, a leading provider of advanced hardware for AI and HPC, announces it is delivering the first NVIDIA DGX A100 system to a higher education institution in the United States

DermTech PLA Included in Peer Review Article of Novel Molecular Technologies for Melanoma Management with Potential to Address Current Gaps in Diagnostic Accuracy and Prognostication

LA JOLLA, CA - May 20, 2020 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the DermTech Pigmented Lesion Assay (the “DermTech PLA”) is reviewed in the Journal of the American Academy of Dermatology (“JAAD”) by leading dermatologists at the New York University School of Medicine as one of four novel molecular technologies with the potential to address current gaps in melanoma management through improved diagnostic accuracy and prognostication

2bPrecise honored as recipient of the 2020 Microsoft Health Innovation Awards

PITTSBURGH, PA, UNITED STATES - May 20, 2020 - 2bPrecise™ Precision Health™ platform has been named a recipient of Microsoft Corp.’s 2020 Health Innovation Awards, in the category of “Reimagine Healthcare

Sterling Pharma Solutions commence the production of potential COVID-19 treatment

DUDLEY, UNITED KINGDOM - May 11, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19